Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 28% ± 8% | |
brain | 13 studies | 32% ± 18% | |
eye | 8 studies | 29% ± 15% | |
peripheral blood | 6 studies | 24% ± 5% | |
pancreas | 3 studies | 25% ± 6% | |
liver | 3 studies | 33% ± 12% | |
intestine | 3 studies | 22% ± 8% | |
prostate | 3 studies | 20% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6987.16 | 1445 / 1445 | 100% | 85.72 | 183 / 183 |
lung | 100% | 11440.43 | 578 / 578 | 100% | 118.88 | 1153 / 1155 |
stomach | 100% | 3402.41 | 359 / 359 | 99% | 54.57 | 284 / 286 |
uterus | 100% | 4169.99 | 170 / 170 | 99% | 91.70 | 455 / 459 |
intestine | 100% | 4806.01 | 966 / 966 | 99% | 60.50 | 522 / 527 |
thymus | 100% | 5115.06 | 653 / 653 | 99% | 76.36 | 599 / 605 |
skin | 100% | 5081.60 | 1809 / 1809 | 99% | 96.18 | 467 / 472 |
prostate | 100% | 5513.69 | 245 / 245 | 99% | 53.29 | 496 / 502 |
brain | 99% | 3411.44 | 2610 / 2642 | 100% | 71.66 | 703 / 705 |
ovary | 100% | 4909.92 | 180 / 180 | 97% | 34.21 | 419 / 430 |
adrenal gland | 100% | 6786.23 | 258 / 258 | 97% | 68.72 | 224 / 230 |
kidney | 100% | 3318.85 | 89 / 89 | 97% | 70.86 | 873 / 901 |
bladder | 100% | 6768.95 | 21 / 21 | 91% | 54.99 | 458 / 504 |
breast | 100% | 4370.10 | 459 / 459 | 86% | 35.35 | 963 / 1118 |
pancreas | 83% | 1259.75 | 271 / 328 | 98% | 66.19 | 174 / 178 |
liver | 62% | 811.72 | 141 / 226 | 44% | 13.84 | 179 / 406 |
adipose | 100% | 4789.23 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4864.28 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 46.91 | 29 / 29 |
spleen | 100% | 5533.18 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 144.74 | 45 / 45 |
heart | 99% | 2696.61 | 856 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 115.03 | 78 / 80 |
peripheral blood | 95% | 3626.11 | 883 / 929 | 0% | 0 | 0 / 0 |
muscle | 76% | 980.04 | 607 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0012505 | Cellular component | endomembrane system |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | RNF145 |
Protein name | RING finger protein 145 (EC 2.3.2.27) |
Synonyms | |
Description | FUNCTION: E3 ubiquitin ligase that catalyzes the direct transfer of ubiquitin from E2 ubiquitin-conjugating enzyme to a specific substrate. In response to bacterial infection, negatively regulates the phagocyte oxidative burst by controlling the turnover of the NADPH oxidase complex subunits. Promotes monoubiquitination of CYBA and 'Lys-48'-linked polyubiquitination and degradation of CYBB NADPH oxidase catalytic subunits, both essential for the generation of antimicrobial reactive oxygen species. Involved in the maintenance of cholesterol homeostasis. In response to high sterol concentrations ubiquitinates HMGCR, a rate-limiting enzyme in cholesterol biosynthesis, and targets it for degradation. The interaction with INSIG1 is required for this function. In addition, triggers ubiquitination of SCAP, likely inhibiting its transport to the Golgi apparatus and the subsequent processing/maturation of SREBPF2, ultimately down-regulating cholesterol biosynthesis. . |
Accessions | ENST00000520638.1 [Q96MT1-4] ENST00000518802.5 [Q96MT1-5] ENST00000519865.5 [Q96MT1-1] ENST00000274542.6 [Q96MT1-2] ENST00000424310.7 [Q96MT1-1] ENST00000521606.6 [Q96MT1-3] Q96MT1 |